To summarize all that we have gathered, the aforementioned data supported a conclusion that BMX-ARHGAP induces the activation of the JAK/STAT3 signaling pathway by upregulating BMX-SH2, underlying a novel mechanism of the oncogenic BMX-ARHGAP fusion in GC (Fig. 6). The gene discussed is STAT3; the disease is gastric cancer.